GlassScriptPhysician profile
Michele Degregorio
NPI 1306808175
$101,938.56
in general payments reported to CMS, 2019-2025
72 companies · $13K in 2025
The $13K reported for 2025 was more than what 95% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $4,868 · 2020: $4,202 · 2021: $5,449 · 2022: $5,093 · 2023: $25K · 2024: $43K · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $31K · Honoraria: $27K · Food and Beverage: $21K · Travel and Lodging: $3,373 · Education: $68.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $30,896.50 |
| Honoraria | $27,340.00 |
| Food and Beverage | $20,647.60 |
| Travel and Lodging | $3,372.97 |
| Education | $68.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lexicon Pharmaceuticals, INC. | $31,265.28 | 2023-2024 | Inpefa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26,625.28 | 2019-2025 | Jardiance |
| Endologix LLC | $7,858.33 | 2019-2025 | Alto Abdominal Stent Graft System, Torus Stent Graft System, Endocross Device |
| Medtronic, INC. | $4,138.18 | 2021-2025 | Corevalve Evolut R, Hawkone, Symplicity G3 |
| Lilly USA, LLC | $3,437.50 | 2023-2025 | Jardiance |
| Abbott Laboratories | $3,324.85 | 2019-2025 | Mitraclip, Perclose Prostyle, Jeti |
| Medtronic Vascular, INC. | $2,292.77 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $2,029.16 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $1,883.69 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $1,790.99 | 2019-2025 | Camzyos, Eliquis, Reblozyl |
| Astrazeneca Pharmaceuticals LP | $1,731.79 | 2019-2025 | Farxiga, Wainua, Brilinta |
| Novartis Pharmaceuticals Corporation | $1,711.88 | 2019-2025 | |
| Edwards Lifesciences Corporation | $1,120.07 | 2023-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Merck Sharp & Dohme LLC | $1,009.68 | 2021-2025 | Verquvo, Capvaxive |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $958.21 | 2019-2025 | Lifevest |
Show all 71 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $937.61 | 2019-2024 | Lux-Dx Insertable Cardiac Monitor |
| Sanofi-Aventis U.S. LLC | $915.50 | 2019-2024 | |
| Shockwave Medical, INC | $760.12 | 2019-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Kestra Medical Technology Services, INC. | $748.03 | 2022-2025 | Assure Wcd |
| Esperion Therapeutics, INC. | $741.15 | 2020-2024 | Nexletol |
| Amarin Pharma, INC. | $624.78 | 2019-2022 | |
| Pfizer INC. | $618.95 | 2019-2025 | |
| Alnylam Pharmaceuticals INC. | $532.65 | 2021-2025 | Onpattro, Amvuttra |
| Amgen INC. | $525.77 | 2019-2024 | Repatha |
| Inari Medical, INC. | $372.38 | 2023-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Novo Nordisk INC | $306.81 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Cordis US Corp. | $268.49 | 2022-2025 | |
| Kiniksa Pharmaceuticals, LTD. | $247.65 | 2021-2023 | Arcalyst |
| Biotronik INC. | $243.95 | 2019-2021 | |
| Cardiovascular Systems INC. | $224.10 | 2019-2021 | |
| Actelion Pharmaceuticals US, INC. | $223.29 | 2019-2025 | Opsumit, Uptravi |
| Regeneron Healthcare Solutions, INC. | $200.20 | 2019-2022 | |
| Teleflex LLC | $157.77 | 2024 | Manta |
| Kowa Pharmaceuticals America, INC. | $157.36 | 2019-2023 | Seglentis, Livalo |
| United Therapeutics Corporation | $138.67 | 2024-2025 | Tyvaso, Tyvaso |
| Cagent Vascular INC | $128.42 | 2025 | Serrantor |
| Abiomed | $114.63 | 2022-2025 | Impella |
| Daiichi Sankyo INC. | $109.50 | 2021-2023 | Injectafer |
| Chiesi USA, INC. | $103.81 | 2022-2025 | Kengreal |
| Imperative Care, INC | $100.31 | 2025 | Symphony Catheter |
| Heartflow, INC. | $99.88 | 2023 | Ffrct |
| W. L. Gore & Associates, INC. | $92.05 | 2020-2023 | Gore Cardioform Septal Occluder |
| Scpharmaceuticals INC. | $78.91 | 2024-2025 | |
| Kiniksa Pharmaceuticals International, Plc | $78.56 | 2024 | Arcalyst |
| Cook Medical LLC | $73.54 | 2019-2024 | Zilver Ptx |
| Baxter Healthcare | $73.38 | 2022 | |
| Angiodynamics, INC. | $70.03 | 2019-2025 | Auryon Laser System 100-120 Vac |
| Reflow Medical INC | $59.91 | 2025 | |
| Cardinal Health 200 LLC | $55.29 | 2020-2021 | |
| Penumbra, INC. | $54.85 | 2020-2025 | Indigo System |
| Astellas Pharma US INC | $53.86 | 2019 | |
| Cvrx, INC. | $52.23 | 2024-2025 | Barostim Neo System |
| Inspire Medical Systems, INC. | $44.40 | 2025 | Inspire |
| Lundbeck LLC | $37.50 | 2019-2021 | |
| Cleerly, INC. | $29.81 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Truvic Medical, INC. | $29.46 | 2022 | |
| Cardiva Medical, INC. | $29.26 | 2022 | |
| Arbor Pharmaceuticals, INC. | $26.02 | 2020-2021 | |
| Bard Peripheral Vascular, INC. | $23.45 | 2023 | Crosser Iq |
| Irhythm Technologies, INC. | $23.21 | 2022 | |
| Amryt Pharma Holdings LTD | $19.24 | 2023 | Juxtapid |
| Tactile Systems Technology INC | $19.09 | 2025 | Nimbl, Flexitouch Plus |
| Avinger INC. | $19.06 | 2022 | |
| Terumo Medical Corporation | $18.81 | 2024 | Angio-Seal |
| Stryker Corporation | $16.18 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Philips North America LLC | $15.43 | 2023 | |
| Bridgebio Pharma, INC. | $13.93 | 2025 | Attruby |
| Cmp Pharma, INC. | $13.62 | 2020 | |
| Osprey Medical INC | $12.88 | 2020 | |
| Bardy Diagnostics, INC. | $12.62 | 2021 | |
| Ekos Corporation | $12.54 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$134.86 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
$42,237.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michele Degregorio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.